Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Pulmonx (LUNG) has reported Total Current Liabilities for 7 consecutive years, with $20.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 17.92% year-over-year to $20.1 million in Q4 2025; TTM through Dec 2025 was $20.1 million, a 17.92% decrease from a year earlier, with the FY2025 full-year figure at $20.1 million, down 17.92% from the prior year.
• Total Current Liabilities was $20.1 million for Q4 2025 at Pulmonx, down from $22.9 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $24.9 million in Q1 2025 and troughed at $14.0 million in Q1 2021.
• A 5-year average of $20.0 million and a median of $20.3 million in 2022 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 46.41% in 2021 and declined 17.92% in 2025, its largest moves.
• Over 5 years, Total Current Liabilities stood at $17.6 million in 2021, then climbed by 5.37% to $18.5 million in 2022, then climbed by 25.23% to $23.2 million in 2023, then rose by 5.53% to $24.4 million in 2024, then decreased by 17.92% to $20.1 million in 2025.
• The last three Total Current Liabilities figures came in at $20.1 million (Q4 2025), $22.9 million (Q3 2025), and $22.4 million (Q2 2025), per Business Quant data.